三博脑科月内获22家机构调研。公司表示，6月14日，全球首例介入式脑机接口辅助人体患肢运动功能 修复试验在我国完成，成功帮助一名偏瘫患者实现运动功能修复。这一成果展示了我国在脑机接口核心 技术上的自主创新能力，标志着我国介入式脑机接口技术在精准控制、神经重建和智能康复领域迈出了 关键一步。 从资金面来看，受利好消息影响，7月31日多只脑机接口概念股获主力资金净流入，昆仑万维、科大讯 飞、创新医疗的净流入额均超亿元，分别净流入3.64亿元、2.26亿元和1.16亿元。乐普医疗、冠昊生 物、爱朋医疗、三博脑科等个股主力资金净流入额居前。 据数据宝，央视新闻报道，为支持药品和医疗器械创新发展，国家医保局制定新上市药品首发价格机 制，新增了100多项与医疗新技术相关的价格项目。国家医保局从立项、定价等方面入手，畅通新技术 的收费通道，助力满足临床急需的新技术新产品加快收益回报。目前已公布的30批立项指南新增涉及新 产品新设备的价格项目100多项，基本形成"价格立项与技术创新并行"的格局。比如神经系统类立项指 南统一设立"脑机接口置入费""脑机接口适配费"等价格项目，脑机接口技术成熟获批进入临床后，可快 速进入临床应用 ...

值得关注的是，临近收盘时，创新医疗、爱朋医疗、三博脑科等多只脑机接口概念股直线拉升，创新医疗一度逼近涨停。从消息 面来看，当天下午，脑机接口板块迎来一则利好消息。据报道，国家医保局支持脑机接口等新技术进入临床并收费。 脑机接口概念股尾盘拉升 7月31日，临近A股尾盘时分，多只脑机接口概念股突然直线拉升，创新医疗涨幅一度达到9.62%，爱朋医疗一度涨超9%，三博 脑科、倍益康、熵基科技、南京熊猫等相关概念股均有拉升动作。 尾盘，再现异动！ 7月31日，A股三大指数集体调整，截至今日收盘，沪指下跌1.18%，深证成指跌1.73%，创业板指跌1.66%。从盘面上看，钢铁、 煤炭、有色等前期过热的板块集体大跌，AI、创新药概念股则逆市上涨。 耳鼻喉类立项指南统一设立"人工耳蜗植入费""发音装置安装费"等价格项目，鼓励医疗机构帮助更多患者"听得见、说得出"。 放射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目，促进高端医疗设备的临床转化应用。 与此同时，为鼓励药品研发创新，国家医保局还制定了新上市药品首发价格机制。 国家医保局医药价格和招标采购司司长王 小宁表示，"我们支持高水平的创新药，在上市初期取得和高 ...

格隆汇7月31日丨三博脑科(301293.SZ)于投资者互动平台表示，公司部分院区部分科室有运用到AI智能 化产品和技术，一定程度上可以提高医疗服务质量和效率，但对公司业绩不会产生重大影响。 ...

转自：新华财经 新华财经北京7月31日电（王媛媛） 7月31日，脑机接口领域再迎利好！受国家医保局支持脑机接口等进入临床并收费消息刺激，脑机接口概念股盘尾拉 升，创新医疗逼近涨停，爱朋医疗、三博脑科跟涨。 消息面上，据央视新闻，为支持药品和医疗器械创新发展，国家医保局制定新上市药品首发价格机制，新增了100多项与医疗新技术相关的价格项目。国家 医保局从立项、定价等方面入手，畅通新技术的收费通道，助力满足临床急需的新技术新产品加快收益回报。目前已公布的30批立项指南新增涉及新产品新 设备的价格项目100多项，基本形成"价格立项与技术创新并行"的格局。比如：神经系统类立项指南统一设立"脑机接口置入费""脑机接口适配费"等价格项 目，脑机接口技术成熟获批进入临床后，可快速进入临床应用并收费。耳鼻喉类立项指南统一设立"人工耳蜗植入费""发音装置安装费"等价格项目，鼓励医 疗机构帮助更多患者"听得见、说得出"。放射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目，促进高端医疗设备的临床转化应用。 开源证券指出，填补脑机接口医疗服务的价格空白，有望加快落地脑机接口落地运用。 公开资料显示，脑机接口是指在生物脑与 ...

Core Viewpoint - Sanbo Brain Science's stock price increased to 50.08 yuan as of July 31, 2025, reflecting a rise of 1.73 yuan from the previous trading day, indicating positive market sentiment towards the company [1]. Company Overview - Sanbo Brain Science specializes in the medical services sector focused on neurosurgery, providing diagnosis, treatment, and rehabilitation services for brain diseases [1]. - The company operates medical institutions in Beijing and covers niche areas such as precision medicine [1]. Market Activity - On July 31, the stock experienced a rapid rebound, with a price increase of over 2% within a 5-minute window from 14:45 to 14:50 [1]. - The trading volume for the day was 145,676 hands, with a total transaction amount reaching 719 million yuan [1]. - There was a net inflow of 27.91 million yuan from major funds on that day, suggesting strong investor interest [1].

Core Viewpoint - The news highlights a significant rise in brain-computer interface (BCI) concept stocks, driven by new pricing mechanisms introduced by the National Healthcare Security Administration (NHSA) to support innovation in pharmaceuticals and medical devices [1] Group 1: Market Reaction - BCI-related stocks surged, with companies like Innovation Medical nearing a trading limit increase, and others such as Aipeng Medical, Sanbo Brain Science, Entropy Technology, Qisheng Technology, and Yanshan Technology also experiencing gains [1] Group 2: Policy Changes - The NHSA has established a new pricing mechanism for newly launched drugs, adding over 100 pricing items related to new medical technologies [1] - Specific pricing items for neurological projects include "brain-computer interface implantation fees" and "brain-computer interface adaptation fees," facilitating rapid clinical application and reimbursement once the technology is approved [1] - For ear, nose, and throat projects, pricing items like "cochlear implant fees" and "speech device installation fees" have been standardized to encourage healthcare institutions to assist more patients in communication [1] - In radiation therapy, pricing items for "proton therapy" and "heavy ion therapy" have been set to promote the clinical application of advanced medical equipment [1]

Core Viewpoint - The news highlights a significant rise in brain-computer interface (BCI) concept stocks, driven by new pricing mechanisms introduced by the National Healthcare Security Administration (NHSA) to support innovation in pharmaceuticals and medical devices [1] Group 1: Market Reaction - BCI-related stocks such as Innovation Medical are nearing their daily limit up, with other companies like Aipeng Medical, Sanbo Brain Science, Entropy Technology, Qisheng Technology, and Yanshan Technology also experiencing gains [1] Group 2: Policy Changes - The NHSA has established a new pricing mechanism for newly launched drugs, adding over 100 pricing items related to new medical technologies [1] - Specific pricing items for the nervous system have been introduced, including "BCI implantation fees" and "BCI adaptation fees," which will facilitate rapid clinical application and charging once BCI technology is approved for clinical use [1] - Guidelines for ear, nose, and throat (ENT) procedures now include pricing for "cochlear implant fees" and "speech device installation fees," encouraging medical institutions to assist more patients in communication [1] - Pricing items for radiation therapy have been standardized, including "proton therapy" and "heavy ion therapy," promoting the clinical application of advanced medical equipment [1]

消息面上，为支持药品和医疗器械创新发展，国家医保局制定新上市药品首发价格机制，新增了100多 项与医疗新技术相关的价格项目。神经系统类立项指南统一设立"脑机接口置入费""脑机接口适配费"等 价格项目，脑机接口技术成熟获批进入临床后，可快速进入临床应用并收费。耳鼻喉类立项指南统一设 立"人工耳蜗植入费""发音装置安装费"等价格项目，鼓励医疗机构帮助更多患者"听得见、说得出"。放 射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目，促进高端医疗设备的临床转化应用。 与此同时，为鼓励药品研发创新，国家医保局还制定了新上市药品首发价格机制。 格隆汇7月31日｜脑机接口概念股拉升，其中，创新医疗逼近涨停，爱朋医疗、三博脑科、熵基科技、 麒盛科技、岩山科技等跟涨。 ...

A股脑机接口概念尾盘异动拉升，爱朋医疗涨超8%，创新医疗、优刻得-W、三博脑科等跟涨。消息面 上，据央视新闻报道，国家医保局支持脑机接口等新技术进入临床并收费。 ...

序号股票简称PE(TTM)PE(静)市净率总市值(元)13三博脑科90.6294.824.2699.59亿行业平均 48.1561.164.30202.33亿行业中值61.3466.033.1865.82亿1药明康德20.6230.044.742839.19亿2康龙化成 30.6331.914.08572.22亿3爱尔眼科33.1134.515.621227.22亿4诺禾致源33.5534.662.6968.22亿5普蕊斯 36.1530.952.7932.94亿6华康洁净36.4152.462.0335.05亿7诺思格39.5940.453.0456.71亿8通策医疗 40.6241.494.94208.03亿9华厦眼科40.8140.212.92172.37亿10凯莱英41.3643.312.39410.97亿11阳光诺和 46.3235.056.0462.18亿12万邦医药47.6937.742.1632.28亿 来源：金融界 股东方面，截至2025年3月31日，三博脑科股东户数37673户，较上次增加3257户，户均持股市值35.28 万元，户均持股数量2.76万股。 三博脑科医院管理集团股份有限公司 ...